Clinical Trial Update: ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial of ASP 8825 for painful diabetic polyneuropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Polyneuropathy

Drugs mentioned

• ASP 8825 (ASP-8825)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diabetic Neuropathies | Phase 2 | Status: TERMINATED